Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Cole

Showing results (761-770 of 805) with videos related to

Pageof 81
Sort By:
Proceedings : a Conference of the American Medical Informatics Association. AMIA Fall Symposium|January 1, 1997
Standardized problem list generation, utilizing the Mayo canonical vocabulary embedded within the Unified Medical Language SystemP L Elkin, D N Mohr, M S Tuttle, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2010
Identification and optimization of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V3 (V1b) receptor antagonistsJeffrey J Letourneau, Christopher M Riviello, Hong Li, et al.
Nucleic Acids Research|December 1, 2016
COSMIC: somatic cancer genetics at high-resolutionSimon A Forbes, David Beare, Harry Boutselakis, et al.
American Journal of Human Genetics|May 12, 2001
The molecular basis of X-linked spondyloepiphyseal dysplasia tardaA K Gedeon, G E Tiller, M Le Merrer, et al.
Journal of Medicinal Chemistry|September 4, 2024
Rational Design, Synthesis, and Structure-Activity Relationship of a Novel Isoquinolinone-Based Series of HBV Capsid Assembly Modulators Leading to the Identification of Clinical Candidate AB-836Andrew G Cole, Steven G Kultgen, Nagraj Mani, et al.
Journal of Medicinal Chemistry|November 8, 2024
Structure-Activity Relationships and Discovery of (<i>S</i>)-5-(<i>tert</i>-Butyl)-11-(difluoromethoxy)-9-methoxy-2-oxo-1,2,5,6-tetrahydropyrido[2',1':2,3]imidazo[4,5-<i>h</i>]quinoline-3-carboxylic Acid (AB-161), a Novel Orally Available and Liver-Centric HBV RNA DestabilizerDimitar Gotchev, Shuai Chen, Benjamin Dugan, et al.
ACS Medicinal Chemistry Letters|September 18, 2024
Conformationally Constrained Isoquinolinones as Orally Efficacious Hepatitis B Capsid Assembly ModulatorsEugen F Mesaros, Andrew G Cole, Steven G Kultgen, et al.
American Journal of Human Genetics|April 16, 1998
Diverse mutations in the gene for cartilage oligomeric matrix protein in the pseudoachondroplasia-multiple epiphyseal dysplasia disease spectrumM D Briggs, G R Mortier, W G Cole, et al.
Human Molecular Genetics|April 4, 2007
COL10A1 nonsense and frame-shift mutations have a gain-of-function effect on the growth plate in human and mouse metaphyseal chondrodysplasia type SchmidMatthew S P Ho, Kwok Yeung Tsang, Rebecca L K Lo, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2009
Orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitorsDmitry O Koltun, Natalya I Vasilevich, Eric Q Parkhill, et al.
Pageof 81

Showing results (761-770 of 805) with videos related to

Sort By:
Pageof 81
Proceedings : a Conference of the American Medical Informatics Association. AMIA Fall Symposium|January 1, 1997
Standardized problem list generation, utilizing the Mayo canonical vocabulary embedded within the Unified Medical Language SystemP L Elkin, D N Mohr, M S Tuttle, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2010
Identification and optimization of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V3 (V1b) receptor antagonistsJeffrey J Letourneau, Christopher M Riviello, Hong Li, et al.
Nucleic Acids Research|December 1, 2016
COSMIC: somatic cancer genetics at high-resolutionSimon A Forbes, David Beare, Harry Boutselakis, et al.
American Journal of Human Genetics|May 12, 2001
The molecular basis of X-linked spondyloepiphyseal dysplasia tardaA K Gedeon, G E Tiller, M Le Merrer, et al.
Journal of Medicinal Chemistry|September 4, 2024
Rational Design, Synthesis, and Structure-Activity Relationship of a Novel Isoquinolinone-Based Series of HBV Capsid Assembly Modulators Leading to the Identification of Clinical Candidate AB-836Andrew G Cole, Steven G Kultgen, Nagraj Mani, et al.
Journal of Medicinal Chemistry|November 8, 2024
Structure-Activity Relationships and Discovery of (<i>S</i>)-5-(<i>tert</i>-Butyl)-11-(difluoromethoxy)-9-methoxy-2-oxo-1,2,5,6-tetrahydropyrido[2',1':2,3]imidazo[4,5-<i>h</i>]quinoline-3-carboxylic Acid (AB-161), a Novel Orally Available and Liver-Centric HBV RNA DestabilizerDimitar Gotchev, Shuai Chen, Benjamin Dugan, et al.
ACS Medicinal Chemistry Letters|September 18, 2024
Conformationally Constrained Isoquinolinones as Orally Efficacious Hepatitis B Capsid Assembly ModulatorsEugen F Mesaros, Andrew G Cole, Steven G Kultgen, et al.
American Journal of Human Genetics|April 16, 1998
Diverse mutations in the gene for cartilage oligomeric matrix protein in the pseudoachondroplasia-multiple epiphyseal dysplasia disease spectrumM D Briggs, G R Mortier, W G Cole, et al.
Human Molecular Genetics|April 4, 2007
COL10A1 nonsense and frame-shift mutations have a gain-of-function effect on the growth plate in human and mouse metaphyseal chondrodysplasia type SchmidMatthew S P Ho, Kwok Yeung Tsang, Rebecca L K Lo, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2009
Orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitorsDmitry O Koltun, Natalya I Vasilevich, Eric Q Parkhill, et al.
Pageof 81